HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Abdulla A. Attum George S. Johnson Zahi Masri Roland Girardet Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Attum, A. A. Articles by Lansing, A. M. Search for Related Content PubMed PubMed Citation Articles by Attum, A. A. Articles by Lansing, A. M.

Ann Thorac Surg 1987;44:217-222
© 1987 The Society of Thoracic Surgeons

---

Articles

Malignant Clinical Behavior of Cardiac Myxomas and "Myxoid Imitators"

Departments of Cardiovascular Surgery and Pathology, Humana Heart Institute International, Louisville, KY

^* Address reprint requests to Dr. Attum, Humana Heart Institute International, One Audubon Plaza Dr, Louisville, KY 40217

The clinical experience with cardiac myxomas and "myxoid imitators" at the Humana Heart Institute International is reviewed and contrasted with a comprehensive review of the world literature. Twenty-two patients with primary cardiac tumors have been treated at our institution. Three (13.6%) of them had myxoid imitators, and 19 had classic myxomas. One of the 19 patients with a classic myxoma had recurrence on two occasions (recurrence rate, 5.3%).

The cases of 57 patients from the world literature are reviewed. Recurrence and/or metastases (including formation of mycotic aneurysm) occurred in approximately 50% of these patients. The overall mortality in these patients was 47%. This review provides documentation of the malignant clinical behavior of cardiac myxomas and myxoid imitators. Neither local recurrence nor regrowth of the tumor in a new location, whether intracardiac or extracardiac, can be predicted from the microscopic appearance of the primary tumor.

Resection of the myxoma with a wide margin is the recommended surgical procedure but does not ensure a cure. Therefore, long-term follow-up is mandatory.

This article has been cited by other articles:

				A. B. Animasahun, O. Y. Kushimo, F. A. Fajuyile, and O. F. Njokanma Atrial Myxoma in 2 Nigerian Children: Case Reports and Review of the Literature World Journal for Pediatric and Congenital Heart Surgery, October 1, 2010; 1(3): 397 - 399. [Abstract] [Full Text] [PDF]

				J.-C. M. Walkes, W. R. Smythe, and M. J. Reardon Cardiac Neoplasms Card. Surg. Adult, January 1, 2008; 3(2008): 1479 - 1510. [Full Text]

				L.-M. Stevens, H. Lapierre, M. Pellerin, I. El-Hamamsy, D. Bouchard, M. Carrier, and L. P. Perrault Atrial versus biatrial approaches for cardiac myxomas Interact CardioVasc Thorac Surg, December 1, 2003; 2(4): 521 - 525. [Abstract] [Full Text] [PDF]

				M. J. Reardon and W. R. Smythe Cardiac Neoplasms Card. Surg. Adult, January 1, 2003; 2(2003): 1373 - 1400. [Full Text]

				F. Bernet, P. M. Stulz, and T. P. Carrel Long-term remission after resection, chemotherapy, and irradiation of a metastatic myxoma Ann. Thorac. Surg., November 1, 1998; 66(5): 1791 - 1792. [Abstract] [Full Text] [PDF]

				J. B. Putnam Jr, M. S. Sweeney, R. Colon, L. A. Lanza, O. H. Frazier, and D. A. Cooley Primary cardiac sarcomas Ann. Thorac. Surg., June 1, 1991; 51(6): 906 - 910. [Abstract] [PDF]

				W. R. Chitwood Jr Cardiac Neoplasms Ann. Thorac. Surg., September 1, 1989; 48(3): 451 - 453. [PDF]